(Q36245361)

13 August 2017

title

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent (English)

1 reference

advanced head and neck cancer

13 August 2017

0 references

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Rodney J Hicks

1

0 references

David Binns

series ordinal

4

object named as

David Binns

1 reference

13 August 2017

6

Lester J Peters

1 reference

13 August 2017

2

Danny Rischin

1 reference

13 August 2017

Richard Fisher

3

1 reference

13 August 2017

Andrew M Scott

series ordinal

5

1 reference

13 August 2017

publication date

26 August 2005

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

13 August 2017

published in

1 reference

13 August 2017

volume

32

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1384-1391

1 reference

SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

13 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-005-1880-2

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

12 December 2020

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

1 reference

12 December 2020

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

12 December 2020

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy

1 reference

12 December 2020

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

1 reference

12 December 2020

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

12 December 2020

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

12 December 2020

Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.

1 reference

12 December 2020

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

12 December 2020

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

1 reference

12 December 2020

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

12 December 2020

Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors

1 reference

12 December 2020

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

12 December 2020

Prognostic significance of tumor oxygenation in humans.

1 reference

12 December 2020

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

1 reference

12 December 2020

Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imaging

1 reference

12 December 2020

10.1007/S00259-005-1880-2

Identifiers

DOI

1 reference

13 August 2017

1 reference